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Obesity-related morbidity and mortality are related to fat accumulation and fat distribution in humans. Two
large-scale meta-analyses recently published in Nature by Shungin et al. (2015) and Locke et al. (2015) report
novel genetic associations for central and overall obesity; these greatly advance our understanding of the
biology of obesity.Obesity poses a major burden on health
and is associated with a higher preva-
lence of chronic disorders. Obesity is
characterized by excessive fat accumula-
tion and intra-abdominal fat deposition
(central obesity) in humans (Figure 1A).
Body mass index (BMI) is used to assess
the extent of general obesity, while waist-
to-hip ratio (WHR), especially after adjust-
ing for BMI, is used as a parameter for
central obesity (apple-shaped or pear-
shaped obesity). Both obesity traits have
been shown to be highly heritable. Previ-
ous genome-wide associated studies
(GWAS) identified 41 genetic loci associ-
ated with BMI and 16 with WHR (Heid
et al., 2010; Speliotes et al., 2010). Two
new meta-analyses (Locke et al., 2015;
Shungin et al., 2015), with sample sizes
of 339,224 and 244,459 human subjects,
respectively, pinpoint to a much longer
list of obesity-associated loci (97 BMI
and 49 WHR loci).
Despite the large number of loci now
discovered, they collectively explain less
than 3% of the phenotypic variation
observed. One important question is,
where is the remaining heritability found?
It has been suggested that a large number
of common DNA variants contribute to the
differences in phenotypic variation but that
individually they have verymodest effects,
whichmakes themdifficult to detect (Rob-
inson et al., 2014). The two meta-studies
have estimated that additional common
variants can account for more than 20%
of BMI variation and 12.1% of WHR varia-
tion. Another question is, how can we
translate this knowledge into disease
mechanisms or even clinical applications?
Over the past 5 years, tremendous ef-
forts have helped identify causal variants
and causal genes from GWAS as a firststep toward understanding the underlying
disease mechanism. This has proved
challenging for three reasons. First, the
lead GWAS SNP is not necessarily a
causal one: the true causal variant can
be identified by more detailed genetic
mapping, by taking advantage of multi-
ethnic groups, and/or by employing
high-density SNP chips (Metabochip).
Nevertheless, genuine proof that a causal
variant has been identified requires addi-
tional mechanistic evidence.
Second, fine mapping is often used to
refine the region of association to a single
gene, which is then marked as disease-
causing. This can be misleading, particu-
larly when the causal SNP does not reside
in the coding region of a gene but maps
to a regulatory region. An example is the
identification of a long-range effect from
the associated SNP at the FTO locus on
the expression of the IRX3 gene, which
lies at a distance of 1.2 Mb from the
SNP (Smemo et al., 2014). FTOwas impli-
cated as an obesity gene in 2007 due to
the strong association of an intronic SNP
with BMI (Dina et al., 2007). Recently,
new evidence for a causal role of IRX3
has emerged from information on the
functional and regulatory elements in
the human genome generated by the
ENCODE consortium (Bernstein et al.,
2012). Prioritizing an incorrect gene may
jeopardize the downstream analysis into
pathways linked to obesity.
A particularly strong point of these two
new meta-studies (Locke et al., 2015;
Shungin et al., 2015) is that they provide
a list of putative candidate genes by
leveraging multiple lines of evidence,
including the functional annotation of
genetic variants, gene expression data,
and expression quantitative trait lociCell Metabolism(eQTL) in multiple tissue types, molecular
pathways, functional predictions, and the
literature. Even then, their results are
complicated. Prioritization tools can only
be based on current knowledge, and
for 41% (23/56) of the new BMI loci
discovered, no putative candidate genes
could be prioritized based on the func-
tional information available. Furthermore,
different prediction tools lead to different
predictions. For example, the eQTL data
suggested putative candidate genes for
28%–36% of the new loci (16 BMI loci
and 12WHR loci). Most of the eQTL genes
are not the genes nearest to the lead
SNPs or genes from functional predic-
tions or the literature.
The third reason is that most of the pri-
oritization tools focus on the coding
potential of the genome but completely
ignore the many more non-coding tran-
scripts that encode for different classes
of regulatory RNA molecules (Lau, 2014).
The genes at different loci do not work
in isolation but are likely to interact with
each other and converge on certain path-
ways and networks. Pathway analyses on
both BMI and WHR loci have yielded
interesting findings, and different biolog-
ical processes have been suggested to
be associated with obesity and central
obesity (Figure 1B). Obesity is a complex
trait, driven by the interaction between
genetic and environmental factors. In
epidemiological studies, lifestyle is often
treated as an environmental factor,
independent of genetic factors. However,
one striking observation is that BMI-asso-
ciated loci are enriched for genes highly
expressed in the central nervous system,
suggesting there is a genetic component
in lifestyle. These genes are thought to
affect appetite, emotion, cognition, and21, April 7, 2015 ª2015 Elsevier Inc. 507
Figure 1. Genetic Analysis Suggests Different Pathways Are Active in Fat Accumulation and
Its Distribution
(A) The risk of obesity in chronic disorders. This risk is not only determined by excessive fat accumulation
but also by intra-abdominal fat deposition (central obesity) in humans. Epidemiologic evidence shows that
central obesity (apple-shape, high waist-to-hip ratio, WHR) contributes a higher risk than general obesity
(high BMI) to many chronic diseases, including cardiovascular diseases and type 2 diabetes.
(B) Biological processes involved in fat accumulation and fat distribution, summarized from the findings of
Shungin et al. and Locke et al. Some of the newly identified genes are listed in bold: the evidence for them
is derived from two independent sources, providing a more compelling reason that these are indeed
causal genes.
Cell Metabolism
Previewsself-control, thereby influencing an indi-
vidual’s energy intake and expenditure.
Some people can be characterized as
‘‘natural-born eaters.’’ In contrast, genes
implicated in adipogenesis, angiogenesis,
and insulin resistance seem to play key
roles in determining an individual’s fat dis-
tribution. For a long time, the field has
been searching for the missing genetic
link between obesity and type 2 diabetes;
this has long been suspected from epide-
miological studies.
We now have convincing evidence for a
genetic link between central obesity and
insulin resistance (Shungin et al., 2015);
some of the WHR-associated genes508 Cell Metabolism 21, April 7, 2015 ª2015act in the processes of insulin secre-
tion and signaling (Figure 1B). Hence,
these findings argue for a reciprocal
relationship between central obesity
and metabolism, together culminating in
cardiovascular complications and other
comorbidities.
The recent work by Shungin et al. and
Locke et al. assessed the association of
obesity-related loci with multiple anthro-
pometric and non-anthropometric traits,
and with metabolic disorders and traits,
thereby providing more mechanistic
insight into obesity and obesity-related
morbidity. However, we still don’t know
whether some of these findings reflectElsevier Inc.a causal relationship or a pleiotropic
association (Li et al., 2014). Answers
to this question will help us better
understand the biology of obesity and
obesity-associated diseases and also
offer strategies for obesity prevention
and treatment.
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